FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.45), $0.11 better than the analyst estimate of ($0.56).

At March 31, 2016, FibroGen had $309.9 million of cash, cash equivalents, investments, receivables and restricted cash

For earnings history and earnings-related data on FibroGen (FGEN) click here.